Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,744 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The tumor immune microenvironment and therapeutic efficacy of trastuzumab deruxtecan in gastric cancer.
Koganemaru S, Koyama S, Suto F, Koga M, Inaki K, Kuwahara Y, Arita T, Hirata T, Goto H, Wada N, Kobayashi M, Shibutani T, Okabayashi T, Nakamaru K, Kawazoe A, Togashi Y, Nishikawa H, Shitara K. Koganemaru S, et al. Among authors: goto h. Cancer Res Commun. 2024 Dec 16. doi: 10.1158/2767-9764.CRC-24-0302. Online ahead of print. Cancer Res Commun. 2024. PMID: 39679910 Free article.
HER3 Augmentation via Blockade of EGFR/AKT Signaling Enhances Anticancer Activity of HER3-Targeting Patritumab Deruxtecan in EGFR-Mutated Non-Small Cell Lung Cancer.
Yonesaka K, Tanizaki J, Maenishi O, Haratani K, Kawakami H, Tanaka K, Hayashi H, Sakai K, Chiba Y, Tsuya A, Goto H, Otsuka E, Okida H, Kobayashi M, Yoshimoto R, Funabashi M, Hashimoto Y, Hirotani K, Kagari T, Nishio K, Nakagawa K. Yonesaka K, et al. Among authors: goto h. Clin Cancer Res. 2022 Jan 15;28(2):390-403. doi: 10.1158/1078-0432.CCR-21-3359. Epub 2021 Dec 17. Clin Cancer Res. 2022. PMID: 34921025
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal Cancer.
Iida N, Imai M, Okamoto W, Kato T, Esaki T, Kato K, Komatsu Y, Yuki S, Masuishi T, Nishina T, Ebi H, Taniguchi H, Nonomura N, Sunakawa Y, Shiozawa M, Yamazaki K, Boku S, Bando H, Shiraishi Y, Kobayashi M, Goto H, Sato A, Fujii S, Yoshino T, Nakamura Y. Iida N, et al. Among authors: goto h. Clin Cancer Res. 2024 Sep 13;30(18):4167-4178. doi: 10.1158/1078-0432.CCR-24-1023. Clin Cancer Res. 2024. PMID: 39163021 Free PMC article.
Chimerism analysis by ABO blood group genotyping with digital droplet PCR.
Naruto T, Sagisaka M, Ito M, Hayashi A, Miyagawa N, Keino D, Yokosuka T, Iwasaki F, Goto H, Yanagimachi M. Naruto T, et al. Among authors: goto h. Int J Hematol. 2024 Dec 17. doi: 10.1007/s12185-024-03898-7. Online ahead of print. Int J Hematol. 2024. PMID: 39688789
Clinical Outcomes of Shifting from Transfemoral-First to Transradial-First Approach in Carotid Artery Stenting: A Retrospective Two-Timeframe Comparison at a Single Center.
Imahori T, Miyake S, Maeda I, Goto H, Nishii R, Enami H, Yamamoto D, Harada T, Tanaka J, Sakata J, Hamaguchi H, Sakai N, Sasayama T, Hosoda K. Imahori T, et al. Among authors: goto h. J Clin Med. 2024 Dec 6;13(23):7432. doi: 10.3390/jcm13237432. J Clin Med. 2024. PMID: 39685890 Free PMC article.
3,744 results